Interestingly, another study showed that when IFNλ2 was administered with PA and 8 hours post-infection, mice had decreased weight loss and immune cell infiltration into alveoli without reduction in bacterial loads, indicating that in this context IFNλ2 may decrease lung inflammation and pathology without increasing clearance (67). The gene discussed is IFNL2; the disease is infection.